Trials / Terminated
TerminatedNCT01264094
A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Bukwang Pharmaceutical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clevudine | clevudine 30 mg qd |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2014-11-01
- Completion
- 2015-06-01
- First posted
- 2010-12-21
- Last updated
- 2015-07-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01264094. Inclusion in this directory is not an endorsement.